Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study

Abstract Background In the UK, hepatitis B virus (HBV) incidence is associated with migrants from particular high-burden countries and population groups deemed ‘hard-to-reach’ by standard healthcare services: the homeless, people who inject drugs and ex-prisoners. Currently, there is a national targ...

Full description

Bibliographic Details
Main Authors: Josephine E. B. Taylor, Julian Surey, Jennifer MacLellan, Marie Francis, Ibrahim Abubakar, Helen R. Stagg
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-019-3926-2
id doaj-d6f31fe8190a4fb6b9fee1f87beb0503
record_format Article
spelling doaj-d6f31fe8190a4fb6b9fee1f87beb05032020-11-25T03:16:20ZengBMCBMC Infectious Diseases1471-23342019-05-011911910.1186/s12879-019-3926-2Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional studyJosephine E. B. Taylor0Julian Surey1Jennifer MacLellan2Marie Francis3Ibrahim Abubakar4Helen R. Stagg5Institute for Global Health, University College London, 4th floor, Mortimer Market CentreInstitute for Global Health, University College London, 4th floor, Mortimer Market CentreInstitute for Global Health, University College London, 4th floor, Mortimer Market CentreInstitute for Global Health, University College London, 4th floor, Mortimer Market CentreInstitute for Global Health, University College London, 4th floor, Mortimer Market CentreInstitute for Global Health, University College London, 4th floor, Mortimer Market CentreAbstract Background In the UK, hepatitis B virus (HBV) incidence is associated with migrants from particular high-burden countries and population groups deemed ‘hard-to-reach’ by standard healthcare services: the homeless, people who inject drugs and ex-prisoners. Currently, there is a national targeted HBV vaccine policy for such at-risk groups, but there is limited recent evidence about 1) the levels of vaccine uptake, 2) the factors associated with incomplete vaccination, and 3) reasons for incomplete vaccination. Methods A questionnaire capturing social and medical history, demographic factors and information about HBV vaccination status was completed by individuals deemed hard-to-reach due to socio-structural factors that criminalise, isolate and stigmatise who consented to participate in a randomised controlled trial of a peer intervention to promote engagement with hepatitis C services. The questionnaire also captured the reasons for incomplete vaccination. Descriptive, univariable and multivariable regression analyses were undertaken. Results Three hundred fourty six participants completed the questionnaire. 1) 52.3% (n = 181) reported full HBV vaccination. 2) Within a multivariable model adjusting for sociodemographic variables, the presence of one or two or more socio-structural factors that are included in the national targeted vaccination policy was associated with protection against incomplete HBV vaccination (51.7% vaccine coverage in those with one factor, odds ratio 0.43 [95% confidence interval 0.20–0.92]); 70.1% coverage with two or more factors, 0.19 [0.09–0.39]; overall p-value < 0.001). Being female was also associated with lower vaccine uptake (2.37 [1.24–4.57], 0.01). Examining the socio-structural factors individually, intravenous drug use was associated with protection against incomplete HBV vaccination. 3) The most common reasons declared for incomplete vaccination were never being offered the vaccine or not returning for further doses. Conclusion Within this study of HBV vaccination uptake among hard-to-reach population groups in London, UK, we document 52.3% coverage of the full vaccine course. Critically, although participants recommended for immunisation within national guidelines had an increased likelihood of receiving a complete vaccine course, we note surprisingly low coverage in the presence of the risk factors that are national indicators for vaccination. Public health bodies should make additional efforts to improve coverage in the hard-to-reach through improved vaccine delivery systems. Trial registration ISRCTN24707359, Registered 19th October 2012.http://link.springer.com/article/10.1186/s12879-019-3926-2Hepatitis B virusVaccinationHard-to-reachPrisonersHomelessInjecting drug users
collection DOAJ
language English
format Article
sources DOAJ
author Josephine E. B. Taylor
Julian Surey
Jennifer MacLellan
Marie Francis
Ibrahim Abubakar
Helen R. Stagg
spellingShingle Josephine E. B. Taylor
Julian Surey
Jennifer MacLellan
Marie Francis
Ibrahim Abubakar
Helen R. Stagg
Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study
BMC Infectious Diseases
Hepatitis B virus
Vaccination
Hard-to-reach
Prisoners
Homeless
Injecting drug users
author_facet Josephine E. B. Taylor
Julian Surey
Jennifer MacLellan
Marie Francis
Ibrahim Abubakar
Helen R. Stagg
author_sort Josephine E. B. Taylor
title Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study
title_short Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study
title_full Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study
title_fullStr Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study
title_full_unstemmed Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study
title_sort hepatitis b vaccination uptake in hard-to-reach populations in london: a cross-sectional study
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2019-05-01
description Abstract Background In the UK, hepatitis B virus (HBV) incidence is associated with migrants from particular high-burden countries and population groups deemed ‘hard-to-reach’ by standard healthcare services: the homeless, people who inject drugs and ex-prisoners. Currently, there is a national targeted HBV vaccine policy for such at-risk groups, but there is limited recent evidence about 1) the levels of vaccine uptake, 2) the factors associated with incomplete vaccination, and 3) reasons for incomplete vaccination. Methods A questionnaire capturing social and medical history, demographic factors and information about HBV vaccination status was completed by individuals deemed hard-to-reach due to socio-structural factors that criminalise, isolate and stigmatise who consented to participate in a randomised controlled trial of a peer intervention to promote engagement with hepatitis C services. The questionnaire also captured the reasons for incomplete vaccination. Descriptive, univariable and multivariable regression analyses were undertaken. Results Three hundred fourty six participants completed the questionnaire. 1) 52.3% (n = 181) reported full HBV vaccination. 2) Within a multivariable model adjusting for sociodemographic variables, the presence of one or two or more socio-structural factors that are included in the national targeted vaccination policy was associated with protection against incomplete HBV vaccination (51.7% vaccine coverage in those with one factor, odds ratio 0.43 [95% confidence interval 0.20–0.92]); 70.1% coverage with two or more factors, 0.19 [0.09–0.39]; overall p-value < 0.001). Being female was also associated with lower vaccine uptake (2.37 [1.24–4.57], 0.01). Examining the socio-structural factors individually, intravenous drug use was associated with protection against incomplete HBV vaccination. 3) The most common reasons declared for incomplete vaccination were never being offered the vaccine or not returning for further doses. Conclusion Within this study of HBV vaccination uptake among hard-to-reach population groups in London, UK, we document 52.3% coverage of the full vaccine course. Critically, although participants recommended for immunisation within national guidelines had an increased likelihood of receiving a complete vaccine course, we note surprisingly low coverage in the presence of the risk factors that are national indicators for vaccination. Public health bodies should make additional efforts to improve coverage in the hard-to-reach through improved vaccine delivery systems. Trial registration ISRCTN24707359, Registered 19th October 2012.
topic Hepatitis B virus
Vaccination
Hard-to-reach
Prisoners
Homeless
Injecting drug users
url http://link.springer.com/article/10.1186/s12879-019-3926-2
work_keys_str_mv AT josephineebtaylor hepatitisbvaccinationuptakeinhardtoreachpopulationsinlondonacrosssectionalstudy
AT juliansurey hepatitisbvaccinationuptakeinhardtoreachpopulationsinlondonacrosssectionalstudy
AT jennifermaclellan hepatitisbvaccinationuptakeinhardtoreachpopulationsinlondonacrosssectionalstudy
AT mariefrancis hepatitisbvaccinationuptakeinhardtoreachpopulationsinlondonacrosssectionalstudy
AT ibrahimabubakar hepatitisbvaccinationuptakeinhardtoreachpopulationsinlondonacrosssectionalstudy
AT helenrstagg hepatitisbvaccinationuptakeinhardtoreachpopulationsinlondonacrosssectionalstudy
_version_ 1724636767409143808